FDA approves Immunomedics' drug for aggressive form of breast cancer

FDA approves Immunomedics' drug for aggressive form of breast cancer

Immunomedics wins FDA approval for new drug to treat aggressive form of breast cancer

By ADAM FEUERSTEIN

COURTESY IMMUNOMEDICS

The drug’s review had been held up for more than a year due to problems at Immunomedics’ New Jersey manufacturing facility, now resolved.

READ MORE